Vai al contenuto principale
Logo Università
Logo di MedInTO Medicine and Surgery

Department of Clinical and Biological Sciences

MedInTO Medicine and Surgery

Logo di MedInTO Medicine and Surgery

Simone Baldovino

Associate Professor

Contacts

At

  • Dipartimento di Scienze Cliniche e Biologiche
  • Corsi di studio in
    Farmacia - Chimica e tecnologia farmaceutiche
  • Corso di laurea in Igiene Dentale
  • Corso di Laurea in Infermieristica - A.O.U. Città della Salute e della Scienza di Torino
  • Corso di Laurea in Infermieristica - Asti
  • Corso di Laurea in Tecniche di Laboratorio Biomedico - Torino
  • Corso di Laurea Magistrale in Odontoiatria e Protesi Dentaria
  • Laurea Magistrale in Medicina e Chirurgia - sede di Torino
  • Laurea magistrale in Medicina e Chirurgia San Luigi Gonzaga
  • MedInTO Medicine and Surgery
  • Scuola di specializzazione in Patologia e Biochimica Clinica
  • Scuola di specializzazione in Nefrologia
  • Master di I livello in Malattie Rare
  • Master di II livello in Reumatologia Pratica
  • Master di I livello in nefrologia e dialisi
  • Master di I livello in linfologia pratica

Curriculum vitae

  • Curriculum Vitae (84.0 KB)

    • Selected research products

    Pubblicazioni 2020 - 2022

    1. Baldovino S, Costanzo P, Roccatello D. Letter by Baldovino et al Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy". Circ Heart Fail. 2022 Jun 24:101161CIRCHEARTFAILURE122009617. doi:10.1161/CIRCHEARTFAILURE.122.009617.
    2. Sciascia S, Barinotti A, Radin M, Cecchi I, Menegatti E, Terzolo E, Rossi D, Baldovino S, Fenoglio R, Roccatello D. Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. J Clin Med. 2022 May 25;11(11):2977. doi:10.3390/jcm11112977.
    3. Radin M, Arbrile M, Cecchi I, Di Nunzio P, Buccarano N, Di Gregorio F, Milone V, Osella S, Crosasso P, Favuzzi MD, Barinotti A, Baldovino S, Menegatti E, Rossi D, Sciascia S, Roccatello D. Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
    4. Fenoglio R, Baldovino S, Barreca A, Bottasso E, Sciascia S, Sbaiz L, Papotti M, Roccatello D. Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease. Nephron. 2022 Mar 18:1-8. doi: 10.1159/000522370.
    5. Arbrile M, Radin M, Rossi D, Menegatti E, Baldovino S, Sciascia S, Roccatello D. Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785.
    6. Sciascia S, Costanzo P, Radin M, Schreiber K, Pini M, Vaccarino A, Cecchi I, Baldovino S, Roccatello D. Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies. Lancet Rheumatol. 2021 Dec;3(12):e832. doi: 10.1016/S2665-9913(21)00320-9.
    7. Vaisitti T, Sorbini M, Callegari M, Kalantari S, Bracciamà V, Arruga F, Vanzino SB, Rendine S, Togliatto G, Giachino D, Pelle A, Cocchi E, Benvenuta C, Baldovino S, Rollino C, Fenoglio R, Sciascia S, Tamagnone M, Vitale C, Calabrese G, Biancone L, Bussolino S, Savoldi S, Borzumati M, Cantaluppi V, Chiappero F, Ungari S, Peruzzi L, Roccatello D, Amoroso A, Deaglio S. Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience. J Nephrol. 2021 Oct;34(5):1767-1781. doi:10.1007/s40620-020-00898-8.
    8. Rossi D, Sciascia S, Fenoglio R, Ferro M, Baldovino S, Kamgaing J, Ventrella F, Kalikatzaros I, Viziello L, Solfietti L, Barreca A, Roccatello D. Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy. Minerva Med. 2021 Apr;112(2):162-174. doi:10.23736/S0026-4806.20.07076-7.
    9. Roccatello D, Fenoglio R, Naretto C, Baldovino S, Sciascia S, Ferro M, Rossi D. Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience. J Clin Med. 2020 Oct 9;9(10):3232. doi:10.3390/jcm9103232.
    10. Salvatore M, Polizzi A, De Stefano MC, Floridia G, Baldovino S, Roccatello D, Sciascia S, Menegatti E, Remuzzi G, Daina E, Iatropoulos P, Bembi B, Da Riol RM, Ferlini A, Neri M, Novelli G, Sangiuolo F, Brancati F, Taruscio D. Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network. Ital J Pediatr. 2020 Sep 14;46(1):130. doi:10.1186/s13052-020-00883-8.
    11. Radin M, Sciascia S, Bazzan M, Bertero T, Carignola R, Montabone E, Montaruli B, Vaccarino A, Cecchi I, Rubini E, Roccatello D, Baldovino S; Piedmont and Aosta Valley APS Consortium. Antiphospholipid Syndrome Is Still a Rare Disease-Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al. Arthritis Rheumatol. 2020 Oct;72(10):1774-1776. doi:10.1002/art.41401.
    12. Sciascia S, Radin M, Ramirez C, Seaman A, Bentow C, Casas S, Cecchi I, Rubini E, Foddai SG, Baldovino S, Fenoglio R, Menegatti E, Roccatello D, Mahler M. Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. Autoimmun Rev. 2020 Oct;19(10):102641. doi:10.1016/j.autrev.2020.102641.
    13. Roccatello D, Fenoglio R, Baldovino S, Naretto C, Ferro M, Barreca A, Rossi D, Sciascia S. Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis. Autoimmun Rev. 2020 Sep;19(9):102622. doi: 10.1016/j.autrev.2020.102622.
    14. Fenoglio R, Baldovino S, Sciascia S, De Simone E, Del Vecchio G, Ferro M, Quattrocchio G, Naretto C, Roccatello D. Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy. J Nephrol. 2021 Apr;34(2):565-571. doi: 10.1007/s40620-020-00781-6.
    15. Roccatello D, Fenoglio R, Sciascia S, Naretto C, Rossi D, Ferro M, Barreca A, Malavasi F, Baldovino S. CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond. Int J Mol Sci. 2020 Jun 10;21(11):4129. doi: 10.3390/ijms21114129.
    16. Fenoglio R, Baldovino S, Ferro M, Sciascia S, Rabajoli G, Quattrocchio G, Beltrame G, Naretto C, Rossi D, Alpa M, Barreca A, Papotti MG, Roccatello D. Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation. J Nephrol. 2021 Feb;34(1):231-240. doi: 10.1007/s40620-020-00748-7.
    17. Sciascia S, Radin M, Cecchi I, Di Nunzio P, Buccarano N, Di Gregorio F, Valeria M, Osella S, Crosasso P, Favuzzi MD, Rubini E, Foddai SG, Baldovino S, Roccatello D, Rossi D. Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study. Int J Environ Res Public Health. 2020 May 15;17(10):3469. doi: 10.3390/ijerph17103469.
    18. Sciascia S, Aprà F, Baffa A, Baldovino S, Boaro D, Boero R, Bonora S, Calcagno A, Cecchi I, Cinnirella G, Converso M, Cozzi M, Crosasso P, De Iaco F, Di Perri G, Eandi M, Fenoglio R, Giusti M, Imperiale D, Imperiale G, Livigni S, Manno E, Massara C, Milone V, Natale G, Navarra M, Oddone V, Osella S, Piccioni P, Radin M, Roccatello D, Rossi D. Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532.
    19. Cabras M, Carrozzo M, Gambino A, Broccoletti R, Sciascia S, Baldovino S, Arduino PG. Value of colchicine as treatment for recurrent oral ulcers: A systematic review. J Oral Pathol Med. 2020 Sep;49(8):731-740. doi:10.1111/jop.13020.
    20. Manganaro M, Baldovino S; Working group of the Piedmont and Aosta Valley Section of the SIN. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy. J Nephrol. 2020 Jun;33(3):393-395. doi:10.1007/s40620-020-00732-1.
    21. Ciaramitaro P, Garbossa D, Peretta P, Piatelli G, Massimi L, Valentini L, Migliaretti G, Baldovino S, Roccatello D, Kodra Y, Taruscio D; Interregional Chiari and Syringomyelia Consortium; on behalf of the Interregional Chiari and Syringomyelia Consortium. Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North-Western Italy cohort. Ann Ist Super Sanita. 2020 Jan-Mar;56(1):48-58. doi:10.4415/ANN_20_01_08.
    22. Sciascia S, Radin M, Baldovino S, Roccatello D. Filling the gap in antiphospholipid syndrome diagnosis: a patient's story. Lupus. 2020 Mar;29(3):236-238. doi: 10.1177/0961203320903810. Epub 2020 Jan 29.
    23. Sciascia S, Radin M, Cecchi I, Fenoglio R, De Marchi A, Besso L, Baldovino S, Rossi D, Miraglia P, Rubini E, Roccatello D. Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. J Nephrol. 2020 Aug;33(4):757-762. doi:10.1007/s40620-019-00698-9.
    24. Sciascia S, Radin M, Cecchi I, Bertolaccini ML, Bertero MT, Rubini E, Vaccarino A, Bazzan M, Giachino O, Baldovino S, Rossi D, Mengozzi G, Roccatello D. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596. PMID: 31840749.
    25. Arduino PG, Broccoletti R, Carbone M, Conrotto D, Sciannameo V, Gambino A, Cabras M, Carrozzo M, Baldovino S. The prompt use of rituximab could decrease adverse effects in patient with pemphigus vulgaris: A preliminary evaluation. J Oral Pathol Med. 2020 Feb;49(2):177-180. doi:10.1111/jop.12982.

    Courses

    Research groups

    Academic bodies

    Office hours

    Ricevimento studenti: al termine delle lezioni o previo appuntamento telefonico (3357552077) o via e-mail (simone.baldovino(at)unito.it)

    Announcements

    AVVISO DI SELEZIONE PER L`AFFIDAMENTO DEGLI INCARICHI DI INSEGNAMENTO, PER LE DISCIPLINE NELL`AMBITO DEI CORSI DI STUDIO DELLE PROFESSIONI SANITARIE ATTIVATE DALL`UNIVERSITA` DEGLI STUDI DI TORINO, DA AFFIDARE AL PERSONALE DEL SSN O PERSONALE CONVENZIONATO CON IL SSR PER L`ANNO ACCADEMICO 2024/2025. SCADENZA: 23 APRILE P.V. LE DOMANDE DOVRANNO ESSERE PRESENTATE SECONDO LE MODALITA` DI CUI ALL`AVVISO SULL`ALLEGATO A, TRAMITE COMPILAZIONE DEL MODULO EDITABILE DENOMINATO ``ALLEGATO B``. LE DISCIPLINE DI INSEGNAMENTO DISPONIBILI SONO INDICATE NELL`ALLEGATO C. PER ULTERIORI INFORMAZIONI RIVOLGERSI ALLA SEGRETERIA DIDATTICA DEL CDL DI INFERMIERISTICA ALLO 0141/33435 E DEL CDL MAGISTRALE IN SCIENZE INFERMIERISTICHE E OSTETRICHE ALLO 0141/483961-62

     

    Last update: 11/03/2024 15:00
    Non cliccare qui!